Us Renal Care Amarillo Dialysis is a medicare approved dialysis facility center in Amarillo, Texas and it has 16 dialysis stations. It is located in Potter county at 1915 S Coulter Street, Amarillo, TX, 79106. You can reach out to the office of Us Renal Care Amarillo Dialysis at (806) 355-3310. This dialysis clinic is managed and/or owned by Us Renal Care, Inc.. Us Renal Care Amarillo Dialysis has the following ownership type - Profit. It was first certified by medicare in October, 2009. The medicare id for this facility is 672614 and it accepts patients under medicare ESRD program.
| Name | Us Renal Care Amarillo Dialysis |
|---|---|
| Location | 1915 S Coulter Street, Amarillo, Texas |
| No. of Dialysis Stations | 16 |
| Medicare ID | 672614 |
| Managed By | Us Renal Care, Inc. |
| Ownership Type | Profit |
| Late Shifts | No |
| 1915 S Coulter Street, Amarillo, Texas, 79106 | |
| (806) 355-3310 | |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
| NPI Number | 1013171495 |
| Organization Name | U.s. Renal Care Amarillo Dialysis |
| Doing Business As | Renal Carepartners Of Amarillo Llc |
| Address | 1915 S Coulter St Amarillo, Texas, 79106 |
| Phone Number | (305) 512-0014 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 23 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 9 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 55 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 443 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 15 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 103 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 80 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Us Renal Care Amarillo Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 66 |
| Hypercalcemia patient months | 551 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 71 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 28 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 14 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 48 |
| Patient months included in arterial venous fistula and catheter summaries | 329 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 58 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 13 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 53 |
| Hospitalization Rate in facility | 158.9 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 280.3 |
| Hospitalization Rate: Lower Confidence Limit | 93.8 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Us Renal Care Amarillo Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 22.6 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 36 |
| Readmission Rate: Lower Confidence Limit | 12.4 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Us Renal Care Amarillo Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .26 (As Expected) |
| SIR: Upper Confidence Limit | 1.28 |
| SIR: Lower Confidence Limit | .01 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Us Renal Care Amarillo Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 47 |
| Transfusion Rate in facility | 51.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 121.9 |
| Transfusion Rate: Lower Confidence Limit | 24.4 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Us Renal Care Amarillo Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 267 |
| Mortality Rate in facility | 17.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.4 |
| Mortality Rate: Lower Confidence Limit | 12.6 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago
Fresenius Medical Care Amarillo High Plains Location: 5920 Amarillo Blvd West, Amarillo, Texas, 79106 Phone: (806) 353-9182 |
Us Renal Care Amarillo Dialysis Location: 1915 S Coulter Street, Amarillo, Texas, 79106 Phone: (806) 355-3310 |
News Archive
As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 6 days ago